Brain Tumour Awards

About this scheme

Key information

Career level
Early career researcher
Mid-career researcher
Established independent researcher
Non-clinical researcher
Clinician
Industry researcher
Health professional
Final submission
Committee review
Funding period
Up to 5 years
Funding amount
Up to £10 million
Brain Tumour Awards allow multidisciplinary teams to coalesce around key basic and translational questions in brain tumour research.

The lead applicant must be:

  • A scientist, clinician or health care worker
  • At a UK university, medical school, hospital or research institution

Collaborators may include international and industry researchers.

Applications will be considered in:

  • Basic biological research: any area of basic biological research relating to brain tumours. Studies may include the use of model systems (e.g. yeast, worm, fly, zebrafish, mouse), cell lines (animal or human) or primary tumour material
  • Preclinical studies: research that will generate biological data to underpin therapeutic development
  • Biomarkers
  • Imaging
  • Radiotherapy research
  • The application of engineering and physical sciences to cancer

Within this scientific remit, we will welcome applications for research into any type of (primary) adult or paediatric brain tumour. However, we are particularly keen to receive proposals that address our priority themes for brain tumours.

 

Funding support is provided for:

  • Salaries for researchers and technical staff
  • PhD Students (stipend, fees and running expenses)
  • Running expenses
  • Equipment

How to apply to this scheme

Application process

Applications for Brain Tumour Awards are now closed. If you have been invited to submit a full application, an form has been opened on our electronic Grants Management System (eGMS).

Before you begin your full application, you must read:

Your application will be judged on the basis of scientific excellence, innovation and importance to furthering our understanding of brain tumours or potential benefits to brain tumour patients.

Applications are assessed by an Expert Review Panel. Final funding decisions are made by our Scientific Executive Board.

Members of the Brain Tumour Award Panel

  • Richard Marais (Chair) – CRUK Manchester Institute, UK
  • Jan Korbel (vice-Chair) – European Molecular Biology Laboratory, Germany
  • Gabriele Bergers – VIB, Belgium
  • Eric Holland – Fred Hutchinson Cancer Center, USA
  • Guillermina Lozano – MD Anderson Cancer Center, USA
  • Tak Mak – University of Toronto, Canada
  • Paul Mischel – University of California San Diego, USA
  • Norbert Perrimon – Harvard Medical School, USA
  • Shonit Punwani – University College London, UK
  • Erik Sulman – New York University, USA

Cancer Research UK contact details

Dr Safia Danovi

Senior Research Funding Manager

brain@cancer.org.uk

+44 (0)20 3469 8399

Research opportunities in brain tumours

[Brain icon]

Brain tumour survival remains low, and has changed little in over a generation. That's why we've made brain tumours a strategic priority as one of our four "cancers of unmet need".

We're boosting our investment into brain tumours, and we have a number of opportunities to help you develop your brain tumour research or to apply your skills to these cancers for the first time.

Tackling hard-to-treat cancers

Illustration of brain

Improving the quality and quantity of research into cancers with the poorest survival rates, including brain and pancreatic cancers, remains a key priority across all aspects of our research activity.

In partnership with

The Brain Tumour Charity